Drug Risk Management Advisory Panel To Be Formed Under Pharm. Science
This article was originally published in The Tan Sheet
Executive Summary
FDA's planned drug risk management advisory committee will be formed as a subcommittee of the Center for Drug Evaluation & Research's Advisory Committee for Pharmaceutical Science
You may also be interested in...
Acetaminophen Toxicity Headed To NDAC, New FDA Drug Safety Group
Potential liver toxicity risks from acetaminophen use are likely to be among the topics at the inaugural meeting of FDA's Drug Safety & Risk Management Subcommittee
Acetaminophen Toxicity Headed To NDAC, New FDA Drug Safety Group
Potential liver toxicity risks from acetaminophen use are likely to be among the topics at the inaugural meeting of FDA's Drug Safety & Risk Management Subcommittee
Acetaminophen Toxicity Headed To NDAC, New FDA Drug Safety Group
Potential liver toxicity risks from acetaminophen use are likely to be among the topics at the inaugural meeting of FDA's Drug Safety & Risk Management Subcommittee